Correction by unknown
Correction  ￿9  The Journal of Experimental Medicine 
In the article "Adjuvant-dependent immune response to malarial transmission-blocking  vaccine candidate antigens" by D. J. Rawlings and D. C. Kaslow 
(November 1992, 176:1483),  the incorrect version  of Figure 1 was printed. Below is the correct version  of Figure 1. 
Figure  1.  Immunogenicity of recombinant Pfi40 emulsified in Freund's 
adjuvant and injected into five congenic mouse strains. Immune sera from 
congenic mouse strains (B10.BR, B10.D2, B10.A[3], B10.S[TR], B10.S[9R.|) 
immunized with either affinity-purified  maltose binding protein (MBP; 
lanes A) or with rPfi40 partially purified from factor Xr  afhnity- 
purified MBP-rPfs40 fusion protein (lanes B) were assayed by immunoblot 
analysis of factor Xc-cleaved, aihnity-purified MBP-rPfi40  fusion protein 
size fractionated by SDS-PAGE under nonreducing conditions and dec- 
troblotted to nitrocellulose.  Although no intact MBP-rPfs40 fusion pro- 
tein was detectable by Western blot, the partially purified preparations 
of rPfs40 contained some MBP, and dicited anti-MBP antibodies in some 
mouse strains (e.g., B10.A[3R]). The solid line indicates the location of 
rPfs40 on the nitrocdhlose blot, and the arrowhead indicates the location 
of MBP. 